Case Reports
doi: 10.1016/s0732-8893(02)00511-4.
Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization
Affiliations
- PMID: 12614988
- DOI: 10.1016/s0732-8893(02)00511-4
Item in Clipboard
Case Reports
Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization
Diagn Microbiol Infect Dis.
2003 Feb.
Abstract
We report a case of infective endocarditis due to vancomycin-intermediate Staphylococcus aureus (VISA) that did not respond to high doses of vancomycin. Initial vancomycin MIC of the last isolate recovered from blood was 8 micro g/mL, but could be induced up to 32 micro g/mL by consecutive growing with vancomycin. Clinical response was only accomplished when linezolid was included in therapy.
Similar articles
-
Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.J Clin Microbiol. 2008 Mar;46(3):1132-6. doi: 10.1128/JCM.01844-07. Epub 2008 Jan 16. J Clin Microbiol. 2008. PMID: 18199793 Free PMC article.
-
Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid.Int J Infect Dis. 2010 Sep;14 Suppl 3:e227-9. doi: 10.1016/j.ijid.2009.07.023. Epub 2009 Dec 14. Int J Infect Dis. 2010. PMID: 20005763
-
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.J Antimicrob Chemother. 2007 Oct;60(4):788-94. doi: 10.1093/jac/dkm258. Epub 2007 Jul 10. J Antimicrob Chemother. 2007. PMID: 17623693
-
Vancomycin-resistant Staphylococcus aureus: a real and present danger?Infection. 2002 Jun;30(3):118-24. doi: 10.1007/s15010-002-2160-8. Infection. 2002. PMID: 12120934 Review.
-
Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus.Eur J Clin Microbiol Infect Dis. 2001 Oct;20(10):685-97. doi: 10.1007/s100960100595. Eur J Clin Microbiol Infect Dis. 2001. PMID: 11757969 Review.
Cited by
-
Infective endocarditis treated with linezolid: case report and literature review.Eur J Clin Microbiol Infect Dis. 2006 Mar;25(3):202-4. doi: 10.1007/s10096-006-0111-5. Eur J Clin Microbiol Infect Dis. 2006. PMID: 16525776 Review. No abstract available.
-
Evidence for reduction in breakpoints used to determine vancomycin susceptibility in Staphylococcus aureus.Antimicrob Agents Chemother. 2005 Sep;49(9):3982-3. doi: 10.1128/AAC.49.9.3982-3983.2005. Antimicrob Agents Chemother. 2005. PMID: 16127089 Free PMC article. No abstract available.
-
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.Sci Rep. 2020 Jul 29;10(1):12689. doi: 10.1038/s41598-020-69058-z. Sci Rep. 2020. PMID: 32728110 Free PMC article.
-
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.Clin Microbiol Rev. 2010 Jan;23(1):99-139. doi: 10.1128/CMR.00042-09. Clin Microbiol Rev. 2010. PMID: 20065327 Free PMC article. Review.
-
First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia.J Clin Microbiol. 2010 Jun;48(6):2199-204. doi: 10.1128/JCM.00954-09. Epub 2010 Apr 14. J Clin Microbiol. 2010. PMID: 20392906 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
